0001437749-24-027905.txt : 20240927 0001437749-24-027905.hdr.sgml : 20240927 20240828113100 ACCESSION NUMBER: 0001437749-24-027905 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 101 GLACIER POINT STREET 2: SUITE A CITY: SAN RAFAEL STATE: CA ZIP: 94901 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 101 GLACIER POINT STREET 2: SUITE A CITY: SAN RAFAEL STATE: CA ZIP: 94901 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 CORRESP 1 filename1.htm ekso20240828_corresp.htm

 

August 28, 2024

 

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention:

Edwin Kim

 

 

Re:

Ekso Bionics Holdings, Inc.

Registration Statement on Form S-1

File No. 333-281081

 

Acceleration Request

 

 

Requested Date:

August 29, 2024
 

Requested Time:

4:30 p.m. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-281081) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.

 

  Sincerely,
     
  EKSO BIONICS HOLDINGS, INC.
     
     
  By: /s/ Scott G. Davis
    Scott G. Davis
    Chief Executive Officer

 

 

cc:

Mark B. Baudler, Wilson Sonsini Goodrich & Rosati

Austin D. March, Wilson Sonsini Goodrich & Rosati